Sionna Therapeutics Inc SION
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $49.61
- Day Range
- $49.30–54.97
- 52-Week Range
- $17.09–54.97
- Bid/Ask
- $20.44 / $65.00
- Shares Outstanding
- 45.21M
- Market Cap
- $2.31B
- Volume/Avg
- 747,527 / 496,651
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 59
- Website
- https://www.sionnatx.com
Valuation
|
Metric
|
SION
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.67 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SION
|
|---|---|
Quick Ratio | 19.57 |
Current Ratio | 20.05 |
Interest Coverage | — |
Quick Ratio
SION
Profitability
|
Metric
|
SION
|
|---|---|
Return on Assets (Normalized) | −23.93% |
Return on Equity (Normalized) | −25.30% |
Return on Invested Capital (Normalized) | −28.45% |
Return on Assets
SION
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>JY^G$ | LOCK|!tHf | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|@ZL@v^F | LOCK|?%tdk | $81B | |||
| argenx SE ADR
ARGX
| LOCK|SxH#k^S | LOCK|$WY | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|MF?@&!m | LOCK|p$^!& | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|g%!pSr | LOCK|CL | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|tB&&R&< | LOCK|z$Gq | $29B | |||
| Incyte Corp
INCY
| LOCK|&GjV$C | LOCK|rm | $24B | |||
| Moderna Inc
MRNA
| LOCK|<v@&!? | LOCK|<rN | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|mfXZmc< | LOCK|N! | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|^@!yqh> | LOCK|c?> | $17B |
United States